Home LiteratureArticle Details
PMID: 10794056 Published · ppublish English Journal Article Review

Memory CD8+ T cells in HIV infection.

McMichael AJ, Ogg G, Wilson J, Callan M, Hambleton S, Appay V, Kelleher T, Rowland-Jones S

Abstract

Cytotoxic T lymphocytes (CTLs) play a central role in the control of persistent HIV infection in humans. The kinetics and general features of the CTL response are similar to those found during other persisting virus infections in humans. During chronic infection there are commonly between 0.1 and 1.0% of all CD8+ T cells in the blood that are specific for immunodominant virus epitopes, as measured by HLA class I peptide tetramers. These figures are greatly in excess of the numbers found by limiting dilution assays; the discrepancy may arise because in the latter assay, CTLs have to divide many times to be detected and many of the HIV-specific CD8+ T cells circulating in infected persons may be incapable of further division. Many tetramer-positive T cells make interferon-gamma, beta-chemokines and perforin, so are probably functional. It is not known how fast these T cells turn over, but in the absence of antigen they decay in number. Impairment of CTL replacement, because CD4+ T helper cells are depleted by HIV infection, may play a major role in the development of AIDS.

MeSH Terms
Animals CD8-Positive T-Lymphocytes/immunology HIV/immunology HIV Infections/immunology Humans Immunologic Memory/immunology
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
McMichael A J
MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. andrew.mcmichael@clinical-medicine.oxford.ac.uk
Ogg G
Wilson J
Callan M
Hambleton S
Appay V
Kelleher T
Rowland-Jones S
References (45)
45 references, click to expand
  1. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
    Science. 1996 Mar 15;271(5255):1582-6 PMID: 8599114
  2. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses.
    J Immunol. 1995 Sep 1;155(5):2729-36 PMID: 7544382
  3. Phenotypic analysis of antigen-specific T lymphocytes.
    Science. 1996 Oct 4;274(5284):94-6 PMID: 8810254
  4. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    Nat Med. 1997 Feb;3(2):205-11 PMID: 9018240
  5. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    Nat Med. 1997 Feb;3(2):212-7 PMID: 9018241
  6. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 PMID: 9050875
  7. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.
    J Exp Med. 1997 Apr 21;185(8):1423-33 PMID: 9126923
  8. Escape of human immunodeficiency virus from immune control.
    Annu Rev Immunol. 1997;15:271-96 PMID: 9143689
  9. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Nature. 1997 May 8;387(6629):183-8 PMID: 9144289
  10. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.
    J Exp Med. 1997 Jul 7;186(1):7-16 PMID: 9206992
  11. Role of cellular immunity in protection against HIV infection.
    Adv Immunol. 1997;65:277-346 PMID: 9238512
  12. Rapid effector function in CD8+ memory T cells.
    J Exp Med. 1997 Sep 15;186(6):859-65 PMID: 9294140
  13. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  14. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Nature. 1998 Jan 22;391(6665):397-401 PMID: 9450757
  15. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  16. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  17. Viral strategies of immune evasion.
    Science. 1998 Apr 10;280(5361):248-53 PMID: 9535648
  18. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.
    Curr Biol. 1998 Mar 26;8(7):413-6 PMID: 9545200
  19. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    J Exp Med. 1998 May 4;187(9):1383-93 PMID: 9565631
  20. T cell responses and viral escape.
    Cell. 1998 May 29;93(5):673-6 PMID: 9630211
  21. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
    Nature. 1998 Jul 30;394(6692):482-5 PMID: 9697771
  22. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific.
    J Exp Med. 1998 Aug 17;188(4):785-90 PMID: 9705961
  23. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  24. Changes in thymic function with age and during the treatment of HIV infection.
    Nature. 1998 Dec 17;396(6712):690-5 PMID: 9872319
  25. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
    J Virol. 1999 Jan;73(1):797-800 PMID: 9847391
  26. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  27. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
    J Immunol. 1999 Feb 1;162(3):1827-35 PMID: 9973448
  28. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome.
    Blood. 1999 Mar 1;93(5):1506-10 PMID: 10029578
  29. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  30. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
    J Virol. 1999 Sep;73(9):7524-32 PMID: 10438842
  31. Declining T-cell immunity to influenza, 1977-82.
    Lancet. 1983 Oct 1;2(8353):762-4 PMID: 6137602
  32. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  33. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
    J Virol. 1990 Aug;64(8):3779-91 PMID: 2370681
  34. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis.
    Immunol Today. 1991 Apr;12(4):102-5 PMID: 1676268
  35. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis.
    J Exp Med. 1992 Oct 1;176(4):1099-106 PMID: 1402655
  36. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    J Exp Med. 1993 Feb 1;177(2):249-56 PMID: 8093890
  37. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
    J Exp Med. 1994 Apr 1;179(4):1261-71 PMID: 8145043
  38. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants.
    Nature. 1994 Jun 2;369(6479):403-7 PMID: 7515165
  39. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  40. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  41. AIDS. Virological mayhem.
    Nature. 1995 Jan 12;373(6510):102 PMID: 7816085
  42. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.
    Eur J Immunol. 1995 Mar;25(3):728-32 PMID: 7705402
  43. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Nature. 1995 Jun 22;375(6533):685-8 PMID: 7540727
  44. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.
    Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5773-7 PMID: 7597028
  45. Immunopathogenic mechanisms of HIV infection.
    Ann Intern Med. 1996 Apr 1;124(7):654-63 PMID: 8607594
Article Info
Journal
Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Abbr.
Philos Trans R Soc Lond B Biol Sci
ISSN
0962-8436
Published
2000-03-29
Pages
363-7
Language
English
Region
England
NLM ID
7503623
PMCID
PMC1692747
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com